With regard to the foregoing, the Board are determined to maximise the market penetration of the product. This will involve a considerable investment by way of working capital to ensure that the product is developed to its full potential and that further rigorous tests are carried out with comparison to our major competitors. The board are well aware that this will be required to penetrate major end users (such as the NHS). To this end, the Board see two major options, namely, a joint venture with the right type of business partner or an agreement to license the product to a major player in the industry.
The investment referred to above is required to ensure that our technical team are resourced to complete the level of comparative testing required to convince end users that Stericile is indeed, the foremost product of its kind in the worldwide marketplace for each industry.
In conclusion, The Board are prepared to consider any means of attracting the level and type of investment required in order to develop Stericlie to its full potential which could include a dilution of the current equity structure or additional equity investment.
|Test Disinfectant||Chlorine (Sodium dichloroisocyanurate)||1 minute – 0.17 – Clean||Stericile|
|Performance against C Diff (log reduction)||1 minute – 0.22 – Clean conditions 60 minutes – 5.8 – Clean conditions||Endosan is the best performing silver hydrogen peroxide||1 minute – 4.91 – Dirty conditions 5 minutes – 5.21 – Dirty conditions|
|Comments||This is the standard against what all other disinfectants are judged||Stericile||Stericile is made from 5% silver stabilised Hydrogen peroxide|